Outcomes & Evidence

    Patient Results

    This page tracks what actually happens to patients after treatment. We include real numbers, anonymised case summaries, and links to verified external reviews — alongside an honest note about what these figures do and don't mean.

    Outcome data in regenerative medicine is hard to present honestly. Conditions vary. Patients vary. Protocols vary. A result in one patient with early-stage knee osteoarthritis doesn't predict the result in a patient with end-stage disease. We think that caveat belongs at the top of the page, not buried in the small print.

    The summaries below are real cases, anonymised. They are not cherry-picked to show only the best outcomes — we've included cases across a range of conditions and response patterns. The numbers in the key metrics section are based on our clinical experience and structured follow-up. They're directional, not statistical certainty, and they're not applicable to every patient or every condition.

    Key numbers

    Based on structured patient follow-up. Individual results vary by condition and protocol. These are not guarantees or RCT-derived figures.

    Mobility & Function

    Physician-led evaluationIndividual assessment and expectations vary
    Physician-led evaluationIndividual assessment and expectations vary
    9,200+Average daily steps at 3 monthsUp from ~3,800 baseline in limited-mobility patients
    Physician-led evaluationIndividual assessment and expectations vary
    Physician-led evaluationIndividual assessment and expectations vary

    Surgery Avoidance

    Physician-led evaluationIndividual assessment and expectations vary
    Physician-led evaluationIndividual assessment and expectations vary

    Speed & Durability

    11–14 daysAverage time to first noticeable improvement
    8–16 wksPeak benefit window
    Physician-led evaluationIndividual assessment and expectations vary

    Patient Experience & Satisfaction

    Physician-led evaluationIndividual assessment and expectations vary
    Physician-led evaluationIndividual assessment and expectations vary
    4.8 / 5Average patient satisfaction score
    0Serious adverse eventsIn the last 18 months of tracked cases

    Longevity & Systemic

    Physician-led evaluationIndividual assessment and expectations vary
    Physician-led evaluationIndividual assessment and expectations vary
    +2.1 ptsSleep quality improvementOn a 10-point scale

    Anonymised case summaries

    Each summary below describes a real patient case. All identifying information has been removed. Conditions, treatments, and outcomes are reported as accurately as follow-up data allows.

    Case A

    Bilateral knee osteoarthritis (Grade II–III)

    Female, 58. History of bilateral knee OA. Two prior cortisone injections with diminishing returns.
    Treatment

    Mesenchymal allogeneic stem cells — bilateral intraarticular injection under ultrasound guidance, combined with PRP and IV preparation protocol

    Result

    The patient reported less daily pain at follow-up and returned to regular walking. Individual responses vary.

    12 weeks to primary outcome
    Case B

    Rotator cuff tendinopathy (partial tear, non-surgical candidate)

    Male, 44. Active recreational athlete. Partial supraspinatus tear confirmed on MRI.
    Treatment

    PRP with growth factor concentration — intraarticular and peritendinous injection under ultrasound guidance

    Result

    Significant reduction in shoulder pain with overhead movement at 8 weeks. Returned to recreational tennis at 16 weeks. Prior physiotherapy over 6 months had plateaued without further improvement.

    16 weeks to return to sport
    Case C

    Post-surgical recovery — total hip replacement

    Male, 67. Elective hip replacement. Protocol initiated 2 weeks post-surgery in coordination with orthopaedic surgeon.
    Treatment

    Exosomes IV + targeted nutritional protocol to support tissue repair and reduce post-operative inflammation

    Result

    Faster-than-expected return to walking without assistive device. Patient and surgical team reported recovery progression ahead of standard timeline. No complications.

    Recovery markers tracked at 4 and 8 weeks
    Case D

    Chronic lower back pain — facet joint degeneration

    Female, 51. Chronic lower back pain for 3 years. Failed NSAID and physiotherapy management.
    Treatment

    PRP injection into affected facet joints under fluoroscopic guidance, combined with functional rehabilitation guidance

    Result

    The patient reported less pain at follow-up and was able to resume part-time work. Individual responses vary.

    Improvement sustained at 6 months
    Case E

    Longevity / systemic anti-aging protocol

    Male, 52. Healthy baseline. Primary motivation: functional longevity and preventive medicine.
    Treatment

    Systemic IV mesenchymal stem cell protocol combined with comprehensive blood panel, hormonal assessment, and IV micronutrient support

    Result

    Patient reported improved energy levels, sleep quality, and cognitive clarity at 6-week follow-up. Inflammatory markers (CRP, IL-6) improved from baseline. Subjective and biomarker improvements noted. Results are variable for systemic protocols and less predictable than condition-specific applications.

    Biomarker reassessment at 6 weeks

    Verified external reviews

    Independent reviews from patients on Google and Tripadvisor. We don't moderate or curate these — they reflect the full range of patient feedback.

    How we collect and use outcomes data

    We conduct structured follow-up consultations at approximately 4–6 weeks and 12 weeks after every protocol. Patients are asked standardised questions about pain, function, and quality of life relevant to their condition. We record this data systematically and use it to evaluate which protocols perform well and which don't — and to refine our clinical approach over time.

    We do not collect outcome data for marketing purposes only. The goal is to improve how we practice — and to be able to give the next patient asking "will this work for me?" a better-grounded answer.

    Patient data is stored confidentially in accordance with Colombian data protection law (Ley 1581 de 2012). Summaries shared publicly are anonymised and shared only with explicit patient consent.

    Want to know if this could work for you?

    Start with a medical evaluation. We'll review your situation honestly and tell you whether there's a protocol that makes sense.